Great West Life Assurance CO Allakos Inc. Transaction History

Great West Life Assurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$5.66 - $8.42 $18,230 - $27,120	3,221 New	3,221 $27,000
Q2 2022 Aug 09, 2022	SELL	$2.6 - $6.14 $4,552 - $10,751	-1,751 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$85.37 - $114.1 $597 - $798	7 Added 0.4%	1,751 $149,000
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $22,604 - $31,653	206 Added 13.39%	1,744 $199,000
Q3 2020 Nov 17, 2020	BUY	$66.43 - $90.99 $102,169 - $139,942	1,538 New	1,538 $125,000
Q3 2020 Nov 13, 2020	SELL	$66.43 - $90.99 $102,169 - $139,942	-1,538 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$66.49 - $137.73 $102,261 - $211,828	1,538 New	1,538 $146,000
Q3 2019 Oct 25, 2019	SELL	$31.0 - $89.73 $55,087 - $159,450	-1,777 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$31.59 - $62.65 $56,135 - $111,329	1,777 New	1,777 $89,000

68.8M

20.9K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $22M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.